The WW domain: linking cell signalling to the membrane cytoskeleton.

The WW domain is one of the smallest yet most versatile protein-protein interaction modules. The ability of this simple domain to interact with a number of proline-containing ligands has resulted in a great deal of functional diversity. Most recently it has been shown that WW domain interactions can also be differentially regulated by tyrosine phosphorylation. Here we briefly review WW domain ligands and structure in comparison to SH3 domain ligands and structure and discuss recent findings with regard to the regulation of WW domain interactions by phosphorylation. In particular we describe the potential for differential binding of the b-dystroglycan WW domain ligand by dystrophin or caveolin-3 in skeletal muscle and show how this could act as a switch to alter the relative affinity of the muscle dystroglycan complex for caveolin-3 or dystrophin and utrophin.

[1]  M. Lisanti,et al.  Expression of Caveolin-3 in Skeletal, Cardiac, and Smooth Muscle Cells , 1996, The Journal of Biological Chemistry.

[2]  B. Mayer,et al.  A novel viral oncogene with structural similarity to phospholipase C , 1988, Nature.

[3]  M. Macias,et al.  Structural analysis of WW domains and design of a WW prototype , 2000, Nature Structural Biology.

[4]  A. Sparks,et al.  Identification of Novel Human WW Domain-containing Proteins by Cloning of Ligand Targets* , 1997, The Journal of Biological Chemistry.

[5]  G. Cesareni,et al.  Contribution of the different modules in the utrophin carboxy‐terminal region to the formation and regulation of the DAP complex , 2000, FEBS letters.

[6]  P. Leder,et al.  FBP WW domains and the Abl SH3 domain bind to a specific class of proline‐rich ligands , 1997, The EMBO journal.

[7]  H. Jarrett,et al.  Ca-Calmodulin Binds to the Carboxyl-terminal Domain of Dystrophin (*) , 1996, The Journal of Biological Chemistry.

[8]  T. Hunter,et al.  NeW Wrinkles for an Old Domain , 2000, Cell.

[9]  F. Zara,et al.  Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy , 1998, Nature Genetics.

[10]  W. Lim,et al.  Converging on proline: the mechanism of WW domain peptide recognition , 2000, Nature Structural Biology.

[11]  J. Forman-Kay,et al.  Solution structure of a Nedd4 WW domain–ENaC peptide complex , 2001, Nature Structural Biology.

[12]  B. André,et al.  WWP, a new amino acid motif present in single or multiple copies in various proteins including dystrophin and the SH3-binding Yes-associated protein YAP65. , 1994, Biochemical and biophysical research communications.

[13]  S J Winder,et al.  The interaction of dystrophin with beta-dystroglycan is regulated by tyrosine phosphorylation. , 2001, Cellular signalling.

[14]  M. Sudol,et al.  The WW domain of Yes-associated protein binds a proline-rich ligand that differs from the consensus established for Src homology 3-binding modules. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Hongtao Yu,et al.  Structural basis for the binding of proline-rich peptides to SH3 domains , 1994, Cell.

[16]  S J Winder,et al.  The complexities of dystroglycan. , 2001, Trends in biochemical sciences.

[17]  S. Schreiber,et al.  Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. , 1995, Science.

[18]  T. Petrucci,et al.  Localization of the dystrophin binding site at the carboxyl terminus of beta-dystroglycan. , 1996, Biochemical and biophysical research communications.

[19]  M. Sudol,et al.  Structure and function of the WW domain. , 1996, Progress in biophysics and molecular biology.

[20]  Scott A. Peterson,et al.  Characterization of the WW Domain of Human Yes-associated Protein and Its Polyproline-containing Ligands* , 1997, The Journal of Biological Chemistry.

[21]  F. Sotgia,et al.  Caveolin-3 directly interacts with the C-terminal tail of beta -dystroglycan. Identification of a central WW-like domain within caveolin family members. , 2000, The Journal of biological chemistry.

[22]  Xin Huang,et al.  Structure of a WW domain containing fragment of dystrophin in complex with β-dystroglycan , 2000, Nature Structural Biology.

[23]  P. Leder,et al.  Formin binding proteins bear WWP/WW domains that bind proline‐rich peptides and functionally resemble SH3 domains. , 1996, The EMBO journal.

[24]  S. Winder.  REVIEW: The membrane--cytoskeleton interface: the role of dystrophin and utrophin , 1997, Journal of Muscle Research & Cell Motility.

[25]  M. Saraste,et al.  Structure of the WW domain of a kinase-associated protein complexed with a proline-rich peptide , 1996, Nature.

[26]  Xiao Zhen Zhou,et al.  Function of WW domains as phosphoserine- or phosphothreonine-binding modules. , 1999, Science.

[27]  P. Bork,et al.  The WW domain: a signalling site in dystrophin? , 1994, Trends in biochemical sciences.

[28]  R. Kriz,et al.  Sequence similarity of phospholipase C with the non-catalytic region of src , 1988, Nature.

[29]  Tony Hunter,et al.  Structural basis for phosphoserine-proline recognition by group IV WW domains , 2000, Nature Structural Biology.

[30]  R. Ranganathan,et al.  Structural and Functional Analysis of the Mitotic Rotamase Pin1 Suggests Substrate Recognition Is Phosphorylation Dependent , 1997, Cell.

[31]  K. Deininger,et al.  The WW Domain of Dystrophin Requires EF-Hands Region to Interact with β-Dystroglycan , 1999, Biological chemistry.

[32]  Wendell A. Lim,et al.  Structural determinants of peptide-binding orientation and of sequence specificity in SH3 domains , 1995, Nature.

[33]  M. Cullen,et al.  Immunogold localization of the 43-kDa dystroglycan at the plasma membrane in control and dystrophic human muscle , 1994, Acta Neuropathologica.

[34]  P. Leder,et al.  A Novel Pro-Arg Motif Recognized by WW Domains* , 2000, The Journal of Biological Chemistry.

[35]  M. Sudol,et al.  The importance of being proline: the interaction of proline‐rich motifs in signaling proteins with their cognate domains , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[36]  K. Campbell,et al.  Identification and Characterization of the Dystrophin Anchoring Site on β-Dystroglycan (*) , 1995, The Journal of Biological Chemistry.

[37]  P. Bucher,et al.  The rsp5‐domain is shared by proteins of diverse functions , 1995, FEBS letters.

[38]  S. Fine,et al.  Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[39]  M. Sudol,et al.  The WW Domain of Neural Protein FE65 Interacts with Proline-rich Motifs in Mena, the Mammalian Homolog of DrosophilaEnabled* , 1997, The Journal of Biological Chemistry.

[40]  S. Winder,et al.  Adhesion-dependent tyrosine phosphorylation of (beta)-dystroglycan regulates its interaction with utrophin. , 2000, Journal of cell science.

[41]  M. Shigekawa,et al.  Bidirectional Signaling between Sarcoglycans and the Integrin Adhesion System in Cultured L6 Myocytes* , 1998, The Journal of Biological Chemistry.